Sakar Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
SAKAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sakar Healthcare Limited has filed its financial results with the stock exchange for the quarter and half-year ended September 30, 2025. This is a routine regulatory disclosure confirming that the company has shared its Q2 FY26 earnings report with the exchanges. The actual numbers, including revenue, profit, and margin details, would be available in the full results document.
This is a standard compliance filing and does not, by itself, signal any positive or negative development. Investors should review the detailed results to assess actual performance, and the stock may react once the full numbers are digested.